Getting SMART for Pediatric Epilepsy

• Status: Recruiting
• Trial end date: 2024-07-30
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to evaluate the effect of melatonin for improving sleep in pediatric epilepsy.

• Phase: Phase 2/Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: National Taiwan University Hospital
• Treatments: Melatonin

Criteria

Inclusion Criteria:

• Children aged between 1 and 18 years with a confirmed diagnosis of epilepsy and with sleep problems

Exclusion Criteria:

• Children who are bedridden with limited mobility

• Children with liver or kidney dysfunction

• Children on medication for sleep or mood problems within 4 weeks before the baseline clinic visit

• Adolescent girls who are pregnant or breastfeeding

• Adolescent girls who have sexual activities but cannot take effective contraceptive measures during the trial